Key result
CR1/2 deficiency in mice significantly increased acute CVB3 myocarditis and pericardial fibrosis, leading to early progression to dilated cardiomyopathy and heart failure.
Why the study?
Does CR1/2 deficiency increase CVB3-induced myocarditis and progression to heart failure in mice?
Does CR1/2 deficiency increase CVB3-induced myocarditis and progression to heart failure in mice?
CR1/2 expression prevents immune-mediated damage to the heart during coxsackievirus B3 infection, highlighting its protective role against progression to dilated cardiomyopathy and heart failure.
CR1/2 may mitigate CVB3 myocarditis progression; hypothesis-generating for complement modulation in human viral cardiomyopathy.
Complement and complement receptors (CR) play a central role in immune defense by initiating the rapid destruction of invading microorganisms, amplifying the innate and adaptive immune responses, and mediating solubilization and clearance of immune complexes. Defects in the expression of C or CR have been associated with loss of tolerance to self proteins and the development of immune complex-mediated autoimmune diseases such as systemic lupus erythematosus. In this study, we examined the role of CR on coxsackievirus B3 (CVB3)-induced myocarditis using mice deficient in CR1/2. We found that CR1/2 deficiency significantly increased acute CVB3 myocarditis and pericardial fibrosis resulting in early progression to dilated cardiomyopathy and heart failure. The increase in inflammation was not due to increased viral replication, which was not significantly altered in the hearts of CR1/2-deficient mice, but was associated with increased numbers of macrophages, IL-1beta levels, and immune complex deposition in the heart. The complement regulatory protein, CR1-related gene/protein Y (Crry), was increased on cardiac macrophage populations, while immature B220(low) B cells were increased in the spleen of CR1/2-deficient mice during acute CVB3-induced myocarditis. These results show that expression of CR1/2 is not necessary for effective clearance of CVB3 infection, but prevents immune-mediated damage to the heart.
No takes yet. Share an insight, caveat, or question.
Fairweather et al. (2006) studied Coxsackievirus B3 (CVB3)-induced myocarditis. CR1/2 deficiency was evaluated on Acute CVB3 myocarditis, pericardial fibrosis, and progression to dilated cardiomyopathy and heart failure. CR1/2 deficiency in mice significantly increased acute CVB3 myocarditis and pericardial fibrosis, leading to early progression to dilated cardiomyopathy and heart failure.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: